240 related articles for article (PubMed ID: 20221430)
1. Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype.
Collins SC; Coffee B; Benke PJ; Berry-Kravis E; Gilbert F; Oostra B; Halley D; Zwick ME; Cutler DJ; Warren ST
PLoS One; 2010 Mar; 5(3):e9476. PubMed ID: 20221430
[TBL] [Abstract][Full Text] [Related]
2. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
[TBL] [Abstract][Full Text] [Related]
3. CGG-repeat dynamics and
Zhou Y; Kumari D; Sciascia N; Usdin K
Mol Autism; 2016; 7():42. PubMed ID: 27713816
[TBL] [Abstract][Full Text] [Related]
4. FMR1 CGG repeat lengths mediate different regulation of reporter gene expression in comparative transient and locus specific integration assays.
Sølvsten C; Nielsen AL
Gene; 2011 Oct; 486(1-2):15-22. PubMed ID: 21767618
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome.
Sheridan SD; Theriault KM; Reis SA; Zhou F; Madison JM; Daheron L; Loring JF; Haggarty SJ
PLoS One; 2011; 6(10):e26203. PubMed ID: 22022567
[TBL] [Abstract][Full Text] [Related]
6. CGG Repeat-Induced FMR1 Silencing Depends on the Expansion Size in Human iPSCs and Neurons Carrying Unmethylated Full Mutations.
Brykczynska U; Pecho-Vrieseling E; Thiemeyer A; Klein J; Fruh I; Doll T; Manneville C; Fuchs S; Iazeolla M; Beibel M; Roma G; Naumann U; Kelley N; Oakeley EJ; Mueller M; Gomez-Mancilla B; Bühler M; Tabolacci E; Chiurazzi P; Neri G; Bouwmeester T; Di Giorgio FP; Fodor BD
Stem Cell Reports; 2016 Dec; 7(6):1059-1071. PubMed ID: 27840045
[TBL] [Abstract][Full Text] [Related]
7. Stable DNA methylation boundaries and expanded trinucleotide repeats: role of DNA insertions.
Naumann A; Kraus C; Hoogeveen A; Ramirez CM; Doerfler W
J Mol Biol; 2014 Jul; 426(14):2554-66. PubMed ID: 24816393
[TBL] [Abstract][Full Text] [Related]
8. Finding FMR1 mosaicism in Fragile X syndrome.
Gonçalves TF; dos Santos JM; Gonçalves AP; Tassone F; Mendoza-Morales G; Ribeiro MG; Kahn E; Boy R; Pimentel MM; Santos-Rebouças CB
Expert Rev Mol Diagn; 2016; 16(4):501-7. PubMed ID: 26716517
[TBL] [Abstract][Full Text] [Related]
9. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
[TBL] [Abstract][Full Text] [Related]
10. Fragile X syndrome and deletions in FMR1: new case and review of the literature.
Hammond LS; Macias MM; Tarleton JC; Shashidhar Pai G
Am J Med Genet; 1997 Nov; 72(4):430-4. PubMed ID: 9375726
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of FMR1 by CRISPR/Cas9-Mediated Deletion of the Expanded CGG-Repeat of the Fragile X Chromosome.
Xie N; Gong H; Suhl JA; Chopra P; Wang T; Warren ST
PLoS One; 2016; 11(10):e0165499. PubMed ID: 27768763
[TBL] [Abstract][Full Text] [Related]
12. Two novel intragenic variants in the FMR1 gene in patients with suspect clinical diagnosis of Fragile X syndrome and no CGG repeat expansion.
Carroll R; Shaw M; Arvio M; Gardner A; Kumar R; Hodgson B; Heron S; McKenzie F; Järvelä I; Gecz J
Eur J Med Genet; 2020 Oct; 63(10):104010. PubMed ID: 32688058
[TBL] [Abstract][Full Text] [Related]
13. Spontaneous rescue of a FMR1 repeat expansion and review of deletions in the FMR1 non-coding region.
Erbs E; Fenger-Grøn J; Jacobsen CM; Lildballe DL; Rasmussen M
Eur J Med Genet; 2021 Aug; 64(8):104244. PubMed ID: 34022415
[TBL] [Abstract][Full Text] [Related]
14. The FMR1 promoter is selectively hydroxymethylated in primary neurons of fragile X syndrome patients.
Esanov R; Andrade NS; Bennison S; Wahlestedt C; Zeier Z
Hum Mol Genet; 2016 Nov; 25(22):4870-4880. PubMed ID: 28173181
[TBL] [Abstract][Full Text] [Related]
15. Clinical and molecular characteristics of FMR1 microdeletion in patient with fragile X syndrome and review of the literature.
Hnoonual A; Plong-On O; Worachotekamjorn J; Charalsawadi C; Limprasert P
Clin Chim Acta; 2024 Jan; 553():117728. PubMed ID: 38142803
[TBL] [Abstract][Full Text] [Related]
16. Rare FMR1 gene mutations causing fragile X syndrome: A review.
Sitzmann AF; Hagelstrom RT; Tassone F; Hagerman RJ; Butler MG
Am J Med Genet A; 2018 Jan; 176(1):11-18. PubMed ID: 29178241
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the clinical utility of a long-read sequencing-based approach in genetic testing of fragile-X syndrome.
Hou F; Mao A; Shan S; Li Y; Meng W; Zhan J; Nie W; Jin H
Clin Chim Acta; 2023 Nov; 551():117614. PubMed ID: 38375623
[TBL] [Abstract][Full Text] [Related]
18. Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.
Peprah E
Ann Hum Genet; 2012 Mar; 76(2):178-91. PubMed ID: 22188182
[TBL] [Abstract][Full Text] [Related]
19. Rescue of Fragile X Syndrome Neurons by DNA Methylation Editing of the FMR1 Gene.
Liu XS; Wu H; Krzisch M; Wu X; Graef J; Muffat J; Hnisz D; Li CH; Yuan B; Xu C; Li Y; Vershkov D; Cacace A; Young RA; Jaenisch R
Cell; 2018 Feb; 172(5):979-992.e6. PubMed ID: 29456084
[TBL] [Abstract][Full Text] [Related]
20. Fragile X syndrome due to a missense mutation.
Myrick LK; Nakamoto-Kinoshita M; Lindor NM; Kirmani S; Cheng X; Warren ST
Eur J Hum Genet; 2014 Oct; 22(10):1185-9. PubMed ID: 24448548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
